Benzinga | Nov 12, 2020 04:20PM EST

ImmuCell Q3 EPS $(0.04) Beats $(0.08) Estimate, Sales $3.72M Beat $3.27M Estimate

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.08) by 50 percent. This is a 42.86 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $3.72 million which beat the analyst consensus estimate of $3.27 million by 13.85 percent. This is a 25.35 percent increase over sales of $2.97 million the same period last year.